The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Share News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cello Group Sees 2013 Profit Increase

Thu, 20th Mar 2014 12:49

LONDON (Alliance News) - Cello Group PLC Thursday reported an increase in profit and revenue for the full-year, reflecting a strong performance across the business.

The marketing consultancy group posted pretax profit of GBP5.5 million for 2013, up from GBP1.4 million, as revenue rose 18.2% to GBP159.7 million, from GBP135.1 million a year earlier.

Cello has two operating divisions, Cello Health and Cello Signal previously Cello Consumer which both performed strongly during the year.

Cello Health, which serves the pharmaceutical industry, saw gross profit rise to GBP35.6 million, from GBP31.3 million. The company won a number of clients during the year including technology firm Sony and NHS Blood Transfusions in the UK. Despite an ongoing senior headcount increase, operating margin increased slightly to 21.2% from 20.8%.

Cello Signal, which advises marketing clients, saw gross profit climb to GBP37.9 million from GBP32.7 million. It also won a number of new clients including Walt Disney and the British Red Cross. Operating margin rose to 10.2% from 9.1%.

Overall, the firm said the 2013 improvement has been underpinned by robust like-for-like gross profit growth of 11.4%.

"This growth has been achieved across the whole business and notably in Cello Signal, where growing digital gross profit and gross profit from technically related services was supplemented by the impact of a significant incremental project," it said.

The growth has also been assisted by the GBP2.1 million acquisition of Mash Health Ltd in January last year. Mash provides consultancy and communication services to a wide portfolio of pharmaceutical, nutraceutical and consumer healthcare clients.

Cello said it is pleased with the performance of the Mash business so far.

Financial net debt fell almost 60% to GBP3.6 million from GBP8.7 million, said the company, which increased its full-year dividend 12.5% to 2.25 pence from 2.00 pence.

The stock was trading at 86.00 pence, down 1.00 pence or 1.2%.

By Anthony Tshibangu; anthonytshibangu@alliancenews.com; @AnthonyAllNews

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
7 Aug 2020 20:11

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

Read more
4 Aug 2020 09:05

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

Read more
1 Jul 2020 12:10

Arsenal Capital makes £179m offer for Cello Health

(Sharecast News) - Cello Health said on Wednesday it had agreed to a takeover from private venture company Arsenal Capital Partners, valuing the company at £179m.

Read more
13 May 2020 16:18

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Apr 2020 12:53

Wednesday broker round-up

(Sharecast News) - Travis Perkins: JP Morgan downgrades to underweight with a target price of 920p.

Read more
7 Apr 2020 12:47

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

Read more
6 Apr 2020 15:17

Access Intelligence Records Widened Annual Loss As Expenses Rise

Access Intelligence Records Widened Annual Loss As Expenses Rise

Read more
18 Mar 2020 14:25

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment

Read more
11 Mar 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
6 Feb 2020 13:32

Cello Health To Pay GBP1.6 Million Back To Access Intelligence

Cello Health To Pay GBP1.6 Million Back To Access Intelligence

Read more
6 Feb 2020 11:21

Cello Health settles with Access Intelligence over Pulsar sale

(Sharecast News) - Healthcare-focussed advisory group Cello Health updated the market on post-completion adjustments in its sale of the Pulsar platform to Access Intelligence on Thursday.

Read more
16 Jan 2020 12:58

Cello Health Reports "Excellent Year" As Restructures Signal Division

Cello Health Reports "Excellent Year" As Restructures Signal Division

Read more
7 Oct 2019 15:23

Cello Health Secures 11% Holding In Access Intelligence

Cello Health Secures 11% Holding In Access Intelligence

Read more
2 Oct 2019 14:15

Cello Health sells Pulsar business to Access Intelligence

(Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.

Read more
2 Oct 2019 10:23

Cello Health Sells Social Media Analytics Unit To Access Intelligence

Cello Health Sells Social Media Analytics Unit To Access Intelligence

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.